Australian respiratory and nasal technology company Rhinomed Limited (ASX:RNO) has
recorded $201,000 in sales of its lead Turbine technology for the June quarter – up from $9,000 in
the previous quarter.
RNO Price at posting:
4.6¢ Sentiment: None Disclosure: Unspecified